Quantcast
Last updated on April 17, 2014 at 14:37 EDT

Monsanto Company to Invest in Technologies for Sugarcane With Acquisitions of CanaVialis and Alellyx

November 3, 2008

ST. LOUIS and SAO PAULO, Brazil, Nov. 3 /PRNewswire-FirstCall/ — In the face of long-term changes driving greater global demand for food and biofuel sources, Monsanto Company is investing in a new large-acre row crop, sugarcane, to diversify its existing core crop portfolio and to leverage its experience in bringing innovations to the agricultural marketplace through breeding and biotechnology. Monsanto announced today that it has entered into a definitive agreement to acquire Aly Participacoes Ltda., which operates the sugarcane breeding and technology companies, CanaVialis S.A. and Alellyx S.A., both of which are based in Brazil. Monsanto’s $290 million (R$616 million) acquisition of Aly Participacoes Ltda. from Votorantim Novos Negocios Ltda. and its sister company, Votorantim Industrial S.A., will be consummated with existing excess cash. Both Votorantim Novos Negocios Ltda. and Votorantim Industrial S.A. are part of the Brazilian industrial conglomerate, Votorantim Participacoes S.A. (commonly referred to as the Votorantim Group). The transaction will be completed as soon as practical.

“Global demands for raw sugar and biofuels are beginning to rise at a faster pace than the current production levels in sugarcane, a crop that is essential to meeting these demands,” said Carl Casale, executive vice president of global strategy and operations for Monsanto. “Similar to our work with technology collaborators, we expect the additions of CanaVialis and Alellyx will allow us to combine our breeding expertise with key large-acre crops with their breeding expertise in sugarcane. Our goal with this approach is to increase yields in sugarcane while reducing the amount of resources needed for this crop’s cultivation, just as we’re doing now for corn, soybeans and cotton. We view this as a significant opportunity over the longer term to supplement our ongoing commitment to corn as an ethanol feedstock, diversify our crop technology portfolio and provide innovations to such a vital crop as sugarcane.”

For Fernando Reinach, executive director of Votorantim Novos Negocios, the acquisitions of CanaVialis and Alellyx by Monsanto will allow the companies to reinforce their technology portfolio, which will help Brazil meet the demand for sugar and ethanol in the intermediate and long terms. “Monsanto’s expertise in advanced breeding and trait development combined with CanaVialis’ and Alellyx’s knowledge of the genetics of sugarcane will help growers to substantially increase productivity in a shorter period of time,” said Reinach.

Sugarcane is a giant perennial plant that typically grows best in tropical climates. As the major source of sugar around the world, sugarcane is planted on more than 50 million acres worldwide, with more than 17 million of those acres residing in Brazil.

CanaVialis is the world’s largest private sugarcane breeding company. Through its breeding activities, CanaVialis is developing and commercializing proprietary germplasm, or a plant’s genetic raw material, that is anticipated to bring significant yields to sugarcane over publicly available varieties. Alellyx is an applied genomics company that is focused on developing biotech traits primarily for sugarcane. Their location and expertise in Brazil are especially important, as Brazil is the world’s largest producer of sugarcane, the largest exporter of finished sugar, and the world’s second-largest producer of ethanol after the United States.

“While we see this move as a long-term investment and a commitment to populating our research and development pipeline, we expect to receive the near-term benefit of access to leading sugarcane germplasm technologies, which can help us accelerate the timeframe for bringing trait technologies to market, possibly around 2016, and bring this germplasm to other sugarcane- growing areas of the world,” said Casale.

Because the acquisition represents a long-term investment in research and development (R&D) and breeding, the company does not expect the acquisition to be accretive to earnings until the middle of the next decade. The company additionally expects a purchase-accounting adjustment for in-process R&D.

The global demand for sugar has intensified in recent years. The International Sugar Organization estimated earlier this year that the world will consume 3.9 million tons more sugar than it will produce in 2008-2009. And both the United Nations’ Food and Agricultural Organization (FAO) and the Food and Agricultural Policy Research Institute (FAPRI) see sugar consumption increasing faster than production over the next decade. As for the world’s growing ethanol demands, the FAO and the Organisation for Economic Co- operation and Development project that global ethanol production will increase rapidly and reach roughly 125 billion liters in 2017, twice the quantity produced in 2007.

Monsanto previously established a licensing and trait-collaboration agreement with CanaVialis and Alellyx in 2007 to develop and commercialize Roundup Ready and Bt insect-protected technologies for sugarcane growers in Brazil. Monsanto intends to retain the leadership and the approximately 250 employees at the two companies and focus on development of the businesses.

The pending acquisitions of CanaVialis and Alellyx represent the third major investment Monsanto has made in Brazil over the past year and reaffirm Monsanto’s commitment to Brazilian agriculture. In 2007, Monsanto acquired Agroeste, a Brazilian corn seed company, and announced $60 million in investments to expand its seeds research and production. Additional information about this acquisition may be found at http://www.monsanto.com/investors.

About CanaVialis and Alellyx

CanaVialis was created in March 2003 from a partnership between Votorantim Novos Negocios and a group of scientists with more than 30 years of experience in the development of sugarcane varieties. CanaVialis has contracts with 46 sugarcane mills whose production area covers 1,100,000 hectares, or approximately 15 percent of the planted sugarcane market share.

Alellyx was created in 2002 by researchers involved in the sequencing of sugarcane and Xylella fastidiosa genomes. Xylella is the bacterium that causes Citrus Variegated Chlorosis, a disease that during the 1990s affected two- thirds of orange plantations in Sao Paulo.

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large- scale farmers to produce more from their land while conserving more of our world’s natural resources such as water and energy. To learn more about our business and our commitments, please visit: http://www.monsanto.com/.

Cautionary Statements Regarding Forward-Looking Information:

Certain statements contained in this release are “forward-looking statements,” such as statements concerning the company’s anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company’s actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company’s exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company’s research and development activities; the outcomes of major lawsuits; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company’s estimates related to distribution inventory levels; the company’s ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company’s facilities; and other risks and factors detailed in the company’s most recent periodic report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.

Note to editor: Roundup Ready is a trademark of Monsanto Company and its wholly owned subsidiaries.

Monsanto Company

CONTACT: Media, Justin Gioia, +1-314-694-4003, or Analysts, Scarlett LeeFoster, +1-314-694-8148, both of Monsanto Company

Web site: http://www.monsanto.com/

Company News On-Call: http://www.prnewswire.com/comp/114341.html